TrialJournal of clinical hypertension (Greenwich, Conn.)2014

Daytime systolic ambulatory blood pressure with a two-step switch from candesartan to olmesartan monotherapy and the fixed-dose combination of olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-2).

Peter Bramlage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.